Drawing for MTEXY

USPTO serial 85788287

MTEXY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HUGHITT, ELIZABETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MTEXY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ahmed Riaz

100 PRNCTN S CORPT CTR STE 300EWING, NJ 08628-3439UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-arthritic compositions and preparations; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of autoimmune diseases and inflammatory diseases; Medicinal preparations for treatment of autoimmune diseases and inflammatory diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of autoimmune diseases and inflammatory diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and inflammatory diseases; Pharmaceutical preparations for treatment, prevention and symptoms of autoimmune diseases and inflammatory diseases; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Preparation for the relief of painACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 27, 2014MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 27, 2014ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 25, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 30, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 30, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 20, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2013DOCKASSIGNED TO EXAMINER—
Dec 6, 2012MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Dec 5, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 30, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance